Simply Inc. buy krebskrebs
Start price
16.08.21
/
50%
€1.67
Target price
16.08.22
€3.50
Performance (%)
-97.01%
End price
17.08.22
-
Summary
This prediction is currently being closed. The BUY prediction by krebskrebs for Simply Inc. is performing very badly with a performance of -97.01%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Simply Inc. | - | - | - | - |
| iShares Core DAX® | -0.681% | -4.853% | 1.940% | 54.334% |
| iShares Nasdaq 100 | -0.033% | 2.862% | 18.901% | 82.618% |
| iShares Nikkei 225® | -0.536% | -5.024% | 28.152% | 55.637% |
| iShares S&P 500 | -0.211% | 0.925% | 13.685% | 61.213% |
Comments by krebskrebs for this prediction
In the thread Simply Inc. diskutieren
In the thread Trading Simply Inc.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten